Literature DB >> 25897539

Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior.

Gillian E Hanley1, Ursula Brain2, Tim F Oberlander3.   

Abstract

BACKGROUND: Animal research has suggested that prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure causes increased anxiety-like behaviors in adulthood. We examined whether in utero SRI exposure influenced externalizing and internalizing behaviors in children at 3 y and again at 6 y of age.
METHODS: We recruited women in their second trimester of pregnancy from primary maternity care providers in Vancouver British Columbia, Canada. We compared the internalizing, externalizing, and the anxious and attention subscales of the internalizing behaviors scores of children exposed to SRIs and children not exposed to SRIs at age 3 and age 6.
RESULTS: We included 110 mother-child pairs (44 exposed to SRI and 66 not exposed). Higher levels of internalizing and anxious behaviors were reported in SRI exposed children at both 3 and 6 y of age compared with children who were not exposed (F = 7.52, P = 0.0072 and F = 7.91, P = 0.0058, respectively). The fully adjusted hierarchical regression models indicated a positive and significant relationship between SRI exposure and increased internalizing and anxious behaviors even when controlling for maternal mood during pregnancy, postpartum and childhood.
CONCLUSION: SRI exposure was associated with sustained higher levels of internalizing behaviors in early childhood even when controlling for maternal depression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25897539     DOI: 10.1038/pr.2015.77

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  37 in total

1.  Neonate characteristics after maternal use of antidepressants in late pregnancy.

Authors:  Bengt Källén
Journal:  Arch Pediatr Adolesc Med       Date:  2004-04

Review 2.  The developmental role of serotonin: news from mouse molecular genetics.

Authors:  Patricia Gaspar; Olivier Cases; Luc Maroteaux
Journal:  Nat Rev Neurosci       Date:  2003-12       Impact factor: 34.870

Review 3.  Anxiety and anxiety disorders in children and adolescents: developmental issues and implications for DSM-V.

Authors:  Katja Beesdo; Susanne Knappe; Daniel S Pine
Journal:  Psychiatr Clin North Am       Date:  2009-09

4.  Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.

Authors:  Dorota Maciag; Kimberly L Simpson; David Coppinger; Yuefeng Lu; Yue Wang; Rick C S Lin; Ian A Paul
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

5.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

6.  Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.

Authors:  Tim F Oberlander; Pratibha Reebye; Shaila Misri; Michael Papsdorf; John Kim; Ruth E Grunau
Journal:  Arch Pediatr Adolesc Med       Date:  2007-01

7.  Perinatal citalopram exposure selectively increases locus ceruleus circuit function in male rats.

Authors:  Ryan D Darling; Loai Alzghoul; Junlin Zhang; Nidhi Khatri; Ian A Paul; Kimberly L Simpson; Rick C S Lin
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

8.  Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons.

Authors:  Charles H K West; James C Ritchie; Katherine A Boss-Williams; Jay M Weiss
Journal:  Int J Neuropsychopharmacol       Date:  2008-10-27       Impact factor: 5.176

9.  Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Authors:  Tim F Oberlander; Shaila Misri; Colleen E Fitzgerald; Xanthoula Kostaras; Dan Rurak; Wayne Riggs
Journal:  J Clin Psychiatry       Date:  2004-02       Impact factor: 4.384

Review 10.  Challenges in developing novel treatments for childhood disorders: lessons from research on anxiety.

Authors:  Daniel S Pine; Sarah M Helfinstein; Yair Bar-Haim; Eric Nelson; Nathan A Fox
Journal:  Neuropsychopharmacology       Date:  2008-08-27       Impact factor: 7.853

View more
  21 in total

1.  Transgenerational hypocortisolism and behavioral disruption are induced by the antidepressant fluoxetine in male zebrafish Danio rerio.

Authors:  Marilyn N Vera-Chang; Antony D St-Jacques; Rémi Gagné; Chris J Martyniuk; Carole L Yauk; Thomas W Moon; Vance L Trudeau
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

Review 2.  Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation.

Authors:  S Brummelte; E Mc Glanaghy; A Bonnin; T F Oberlander
Journal:  Neuroscience       Date:  2016-02-22       Impact factor: 3.590

Review 3.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 4.  Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.

Authors:  Matthew E Glover; Sarah M Clinton
Journal:  Int J Dev Neurosci       Date:  2016-05-07       Impact factor: 2.457

5.  Perceptual interference processing in preschool children, with and without prenatal exposure to selective serotonin reuptake inhibitors.

Authors:  Tone Kristine Hermansen; Santeri Yrttiaho; Espen Røysamb; Annika Melinder
Journal:  Psychopharmacology (Berl)       Date:  2016-11-08       Impact factor: 4.530

6.  Perinatal SSRI exposure permanently alters cerebral serotonin receptor mRNA in mice but does not impact adult behaviors.

Authors:  Lauritz R Meyer; Benjamin Dexter; Cecilia Lo; Elizabeth Kenkel; Takahito Hirai; Robert D Roghair; Sarah E Haskell
Journal:  J Matern Fetal Neonatal Med       Date:  2017-04-24

7.  School-age social behavior and pragmatic language ability in children with prenatal serotonin reuptake inhibitor exposure.

Authors:  Erica L Smearman; Cassandra L Hendrix; Dominika A Winiarski; Katrina C Johnson; Alicia K Smith; Opal Y Ousley; Zachary N Stowe; D Jeffrey Newport; Patricia A Brennan
Journal:  Dev Psychopathol       Date:  2020-02

Review 8.  Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.

Authors:  Sura Alwan; Jan M Friedman; Christina Chambers
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

Review 9.  Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.

Authors:  Katharine Baratz Dalke; Amy Wenzel; Deborah R Kim
Journal:  Curr Psychiatry Rep       Date:  2016-06       Impact factor: 5.285

10.  Long-Term Effects of Intrauterine Exposure to Antidepressants on Physical, Neurodevelopmental, and Psychiatric Outcomes: A Systematic Review.

Authors:  Anna-Sophie Rommel; Veerle Bergink; Xiaoqin Liu; Trine Munk-Olsen; Nina Maren Molenaar
Journal:  J Clin Psychiatry       Date:  2020-05-12       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.